title: Bilateral infiltrative orbital disease: is it chemically induced?
authors.forename: Vijay
authors.initials: V
authors.lastname: Hegde
authors.forename: Danny
authors.initials: D
authors.lastname: Mitry
authors.forename: David
authors.initials: D
authors.lastname: Snead
authors.forename: Harpreet
authors.initials: H
authors.lastname: Ahluwalia
mesh_terms: D000368:Aged; D001249:Asthma / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D005094:Exophthalmos / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D007839:Functional Laterality; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009784:Occupational Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D016273:Occupational Exposure / Q000009:adverse effects*; D000857:Olfaction Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D009916:Orbital Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D009943:Organophosphorus Compounds / Q000009:adverse effects; D011239:Prednisolone / Q000627:therapeutic use; D019310:Pseudolymphoma / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D013447:Sulfites / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed; D014881:Water Supply
chemical_list: D005938:Glucocorticoids; D009943:Organophosphorus Compounds; D013447:Sulfites; C041182:(nitrilotris(methylene))triphosphonic acid; C005200:sodium metabisulfite; D011239:Prednisolone; C025026:sodium sulfite